Biomedical products
Data
Feature
Plans
Sign Up for Free
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Drug Insights
2 min read
Synapse Simplified: How to Find Allopurinol Information
22 February 2024
Allopurinol, sold as Zyloprim®, is a drug that reduces uric acid in gout, kidney stones, and some cancers.
Read →
Latest Hotspot
3 min read
ATA3219 New Drug Application Filed by Atara for Lupus Kidney Treatment
22 February 2024
Atara Biotherapeutics Reports Filing a New Drug Application for ATA3219 Aimed at Treating Lupus Kidney Inflammation.
Read →
Drug Insights
2 min read
A Complete Guide to Searching Aripiprazole on Synapse
22 February 2024
Aripiprazole, sold as Abilify Discmelt®, is an atypical antipsychotic for treating schizophrenia, bipolar disorder, depression, autism-related irritability, and Tourette's syndrome.
Read →
Latest Hotspot
4 min read
FDA Approves CalciMedica's Phase 2 Trial of Auxora™ for Severe Acute Kidney Injury
22 February 2024
CalciMedica has received approval from the FDA to proceed with a Phase 2 study of Auxora™ in treating severe cases of acute kidney injury.
Read →
Drug Insights
2 min read
Using Synapse for Your Guaifenesin Research: An Easy Guide
22 February 2024
Guaifenesin, approved for medical use in Japan in 1949, is an expectorant medication found in numerous over-the-counter products.
Read →
Latest Hotspot
3 min read
Artax Begins Phase 2a Psoriasis Trial with First Participant Dosed with AX-158
22 February 2024
Artax has initiated the dosing of the inaugural participant in their Phase 2a clinical study for Psoriasis, assessing the effects of compound AX-158.
Read →
Drug Insights
2 min read
Accessing Ketorolac Information on Synapse: A Step-by-Step Approach
22 February 2024
Ketorolac Tromethamine, or Toradol®, is an NSAID used to treat moderate to severe pain.
Read →
Latest Hotspot
3 min read
Otsuka Announces AVP-786 Trial Results for Alzheimer's Agitation
21 February 2024
Otsuka Reveals Key Outcomes from Final Stage Trial of AVP-786 for Managing Alzheimer’s-Related Dementia Agitation.
Read →
Drug Insights
2 min read
Maximize Your Synapse Use: Your Guide to Searching Olanzapine
21 February 2024
Zyprexa® (Olanzapine), an antipsychotic, is commonly used to treat schizophrenia, bipolar 1, and related agitation.
Read →
Latest Hotspot
3 min read
Alisertib Phase II Trial for Small Cell Lung Cancer Begins: ALISCA-Lung1
20 February 2024
Puma Biotechnology has launched a Phase II study for Alisertib, targeting Small Cell Lung Cancer, named ALISCA-Lung1.
Read →
Clinical Progress
4 min read
Zelenirstat: A Quick Look at Its R&D Progress and Clinical Results from the 2024 ASCO_GI
20 February 2024
Zelenirstat, an effective oral NMT inhibitor, showed promising results in treating advanced relapsed/refractory cancer at 2024's ASCO_GI.
Read →
Latest Hotspot
3 min read
Galderma's Nemolizumab for Prurigo Nodularis and Eczema Approved for Submission in US and EU
20 February 2024
Galderma declares submission approval of Nemolizumab for treating Prurigo Nodularis and Eczema in America and Europe.
Read →
<
1
<<
136
137
138
139
140
>>
303
>